KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Molina Healthcare (MOH) over the last 17 years, with Q4 2025 value amounting to $4.2 billion.

  • Molina Healthcare's Cash & Equivalents fell 888.03% to $4.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.2 billion, marking a year-over-year decrease of 888.03%. This contributed to the annual value of $4.2 billion for FY2025, which is 888.03% down from last year.
  • Latest data reveals that Molina Healthcare reported Cash & Equivalents of $4.2 billion as of Q4 2025, which was down 888.03% from $4.2 billion recorded in Q3 2025.
  • In the past 5 years, Molina Healthcare's Cash & Equivalents ranged from a high of $5.6 billion in Q3 2023 and a low of $4.0 billion during Q4 2022
  • Its 5-year average for Cash & Equivalents is $4.6 billion, with a median of $4.5 billion in 2024.
  • Per our database at Business Quant, Molina Healthcare's Cash & Equivalents soared by 8735.73% in 2021 and then plummeted by 1496.86% in 2024.
  • Molina Healthcare's Cash & Equivalents (Quarter) stood at $4.4 billion in 2021, then fell by 9.73% to $4.0 billion in 2022, then rose by 21.02% to $4.8 billion in 2023, then fell by 3.84% to $4.7 billion in 2024, then dropped by 8.88% to $4.2 billion in 2025.
  • Its Cash & Equivalents was $4.2 billion in Q4 2025, compared to $4.2 billion in Q3 2025 and $4.5 billion in Q2 2025.